It has been tough sledding for fans of dividend stocks lately, but the latest economic news could help to smooth out the ride. Long-term bond yields have tumbled as a result, which should be good news ...

GSK's Jemperli wins EU approval for broader use in advanced endometrial cancer, showing improved survival and significant ...

The EC has approved GSK's Jemperli (dostarlimab) combined with chemotherapy for primary advanced or recurrent endometrial cancer in adults.

London: GSK plc has announced the European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy ...

European Commission approves GSK’s Jemperli plus chemotherapy to treat patients with primary advanced or recurrent endometrial cancer: London, UK Tuesday, January 21, 2025, 09:0 ...

The European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for ...

GSK plc (LSE/NYSE: GSK) today announced the European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult ...

European regulators have expanded the usage of GSK's Jemperli drug for endometrial cancer, the pharmaceutical firm announced ...

A recent SBI report has stirred the proverbial hornet’s nest with its claims of a sharp reduction in India’s poverty levels, ...

Poverty declined faster in rural areas during FY24 as the poverty ratio dipped below 5 per cent for the first time to 4.86 per cent from 7.2 per cent in FY23, according to a study by SBI Research ...

Sixteen critical government datasets are delayed, and nine Union ministries have not released their annual reports--some of them for several years. The Census of India is now three years overdue.

Researchers at the University of Hawaiʻi at Mānoa’s Hawaiʻi Institute of Marine Biology have used drones to analyze the health of nursing humpback whale mothers and their calves during their ...